NORTHVALE, N.J., Dec. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP) today announced that Elite has in place an agreement for the next year with the Company’s sole supplier of the active pharmaceutical ingredient (“API”) for Elite’s Phentermine product lines which include Phentermine HCl tablets 37.5 mg. and Phentermine HCl capsules 15 mg. and 30 mg.
